Trevi Therapeutics Inc <TRVI.O>: BMO initiates coverage with outperform rating; target price $36
TRVI•Related News
Novo sues Lilly, claiming misleading ads in weight-loss drug battle
LLY•
Houthis warn shipping companies to avoid Saudi ports, email shows
XLE•
Google updates lightweight Gemini models, but flagship still delayed
GOOGL•
NXG Cushing Midstream Energy Fund director John Alban sells 500 common shares worth $23,962.00
SRV•
Agios scraps sickle cell treatment after trial shows limited benefit
AGIO•